Vasoprotective effects of life span-extending peripubertal GH replacement in lewis dwarf rats

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65 A, Issue 11, 2010, Pages 1145-1156

  Ungvari, Zoltan ^a   Gautam, Tripti ^a   Koncz, Peter ^a   Henthorn, Jim C ^a   Pinto, John T ^b   Ballabh, Praveen ^b   Yan, Han ^a   Mitschelen, Matthew ^a   Farley, Julie ^a   Sonntag, William E ^a   Csiszar, Anna ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

GH deficiency; GH replacement; IGF 1 deficiency; Oxidative stress; Vasoprotection

Indexed keywords

RATTUS;

ASCORBIC ACID; BIOLOGICAL MARKER; GCLC PROTEIN, RAT; GLUTAMATE CYSTEINE LIGASE; GLUTATHIONE PEROXIDASE; GROWTH HORMONE; NITRIC OXIDE SYNTHASE; NQO1 PROTEIN, RAT; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); SOMATOMEDIN C;

ANIMAL; ARTICLE; BLOOD VESSEL; BODY WEIGHT; DRUG EFFECT; DWARFISM; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LEWIS RAT; LONGEVITY; METABOLISM; OXIDATIVE STRESS; PHENOTYPE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROKE; VASCULAR ENDOTHELIUM;

ANIMALS; ASCORBIC ACID; BIOLOGICAL MARKERS; BLOOD VESSELS; BODY WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DWARFISM; ENDOTHELIUM, VASCULAR; GLUTAMATE-CYSTEINE LIGASE; GLUTATHIONE PEROXIDASE; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; LONGEVITY; NAD(P)H DEHYDROGENASE (QUINONE); NITRIC OXIDE SYNTHASE; OXIDATIVE STRESS; PHENOTYPE; RATS; RATS, INBRED LEW; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROKE;

EID: 77958061482     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq147     Document Type: Article

References (51)

1. Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990;336(8710):285-288.
2. Bates AS, Van't Hoff W, Jones PJ, Clayton RN. The effect of hypopituitarism on life expectancy. J Clin Endocrinol Metab. 1996;81(3):1169-1172.
3. Bulow B, Hagmar L, Mikoczy Z, Nordstrom CH, Erfurth EM. Increased cerebrovascular mortality in patients with hypopituitarism. Clin Endocrinol (Oxf). 1997;46(1):75-81.
4. Tomlinson JW, Holden N, Hills RK, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypo-pituitary Study Group. Lancet. 2001;357(9254):425-431.
5. Vasan RS, Sullivan LM, D'Agostino RB, et al. Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med. 2003;139(8):642-648.
6. Laughlin GA, Barrett-Connor E, Criqui MH, Kritz-Silverstein D. The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study. J Clin Endocrinol Metab. 2004;89(1):114-120.
7. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. Dwarf mice and the ageing process. Nature. 1996;384(6604):33.
8. Flurkey K, Papaconstantinou J, Miller RA, Harrison DE. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci \USA. 2001;98(12):6736-6741.
9. Carter CS, Ramsey MM, Sonntag WE. A critical analysis of the role of growth hormone and IGF-1 in aging and lifespan. Trends Genet. 2002;18(6):295-301.
10. Holzenberger M, Dupont J, Ducos B, et al. IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature. 2003; 421(6919):182-187.
11. Sonntag WE, Carter CS, Ikeno Y, et al. Adult-onset growth hormone and insulin-like growth factor I defciency reduces neoplastic disease, modifes age-related pathology, and increases life span. Endocrinology. 2005;146(7):2920-2932.
12. Nieves-Martinez E, Sonntag WE, Wilson A, et al. Early-onset GH defciency results in spatial memory impairment in mid-life and is prevented by GH supplementation. J Endocrinol. 2010;204(1): 31-36.
13. Csiszar A, Labinskyy N, Perez V, et al. Endothelial function and vascular oxidative stress in long-lived GH/IGF-defcient Ames dwarf mice. Am J Physiol Heart Circ Physiol. 2008;295(5): H1882-H1894.
14. Smith JC, Evans LM, Wilkinson I, et al. Effects of GH replacement on endothelial function and large-artery stiffness in GH-defcient adults: a randomized, double-blind, placebo-controlled study. Clin Endocrinol (Oxf). 2002;56(4):493-501.
15. Evans LM, Davies JS, Goodfellow J, Rees JA, Scanlon MF Endothelial dysfunction in hypopituitary adults with growth hormone defciency. Clin Endocrinol (Oxf). 1999;50(4):457-464.
16. Evans LM, Davies JS, Anderson RA, et al. The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone defciency. Eur J Endocrinol. 2000;142(3): 254-262.
17. Sukhanov S, Higashi Y, Shai SY, et al. IGF-1 reduces infammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-defcient mice. Arterioscler Thromb Vasc Biol. 2007;27(12):2684-2690.
18. Titterington JS, Sukhanov S, Higashi Y, Vaughn C, Bowers C, Delafontaine P. Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE-/-mice but does not reduce atherosclerosis. Endocrinology. 2009;150(12):5478-5487.
19. Charlton HM, Clark RG, Robinson IC, et al. Growth hormone-defcient dwarfsm in the rat: a new mutation. J Endocrinol. 1988;119(1):51-58.
20. Carter CS, Ramsey MM, Ingram RL, et al. Models of growth hormone and IGF-1 defciency: applications to studies of aging processes and life-span determination. J Gerontol A Biol Sci. 2002;57(5): B177-B188.
21. Hua K, Forbes ME, Lichtenwalner RJ, Sonntag WE, Riddle DR. Adult-onset defciency in growth hormone and insulin-like growth factor-I alters oligodendrocyte turnover in the corpus callosum. Glia. 2009; 57(10):1062-1071.
22. Ramsey MM, Ingram RL, Cashion AB, et al. Growth hormone-defcient dwarf animals are resistant to dimethylbenzanthracine (DMBA)-induced mammary carcinogenesis. Endocrinology. 2002; 143(10):4139-4142.
23. Csiszar A, Labinskyy N, Orosz Z, Xiangmin Z, Buffenstein R, Un-gvari Z. Vascular aging in the longest-living rodent, the naked mole rat. Am J Physiol. 2007;293(2):H919-H927.
24. Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A. High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase. Circulation. 2003;108(10):1253-1258.
25. Csiszar A, Labinskyy N, Jimenez R, et al. Anti-oxidative and anti-infammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1. Mech Ageing Dev. 2009;130(8):518-527.
26. Csiszar A, Ungvari Z, Edwards JG, et al. Aging-induced phenotypic changes and oxidative stress impair coronary arteriolar function. Circ Res. 2002;90(11):1159-1166.
27. Csiszar A, Labinskyy N, Smith K, Rivera A, Orosz Z, Ungvari Z. Vasculoprotective effects of anti-TNFalpha treatment in aging. Am J Pathol. 2007;170(1):388-698.
28. Ungvari ZI, Labinskyy N, Gupte SA, Chander PN, Edwards JG, Csiszar A. Dysregulation of mitochondrial biogenesis in vascular endothelial and smooth muscle cells of aged rats. Am J Physiol Heart Circ Physiol. 2008;294(5):H2121- H2128.
29. Ungvari ZI, Orosz Z, Labinskyy N, et al. Increased mitochondrial H2O2 production promotes endothelial NF-kB activation in aged rat arteries. Am J Physiol Heart Circ Physiol. 2007;293(1):H37-H47.
30. Csiszar A, Smith K, Labinskyy N, Orosz Z, Rivera A, Ungvari Z. Resveratrol attenuates TNF-{alpha}-induced activation of coronary arterial endothelial cells: role of NF-{kappa}B inhibition. Am J Physiol. 2006;291(4):H1694-H1699.
31. Argente J, Barrios V, Pozo J, et al. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: age-and sex-related changes. J Clin Endocrinol Metab. 1993;77(6):1522-1528.
32. Groban L, Pailes NA, Bennett CD, et al. Growth hormone replacement attenuates diastolic dysfunction and cardiac angiotensin-II- expression in senescent rats. J Gerontol A Biol Sci Med Sci. 2006;61(1):28-35.
33. Sonntag WE, Lynch CD, Cooney PT, Hutchins PM. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1. Endocrinology. 1997;138(8):3515-3520.
34. Everitt AV The neuroendocrine system and aging. Gerontology. 1980;26(2):108-119.
35. van der Loo B, Bachschmid M, Spitzer V, Brey L, Ullrich V, Luscher TF. Decreased plasma and tissue levels of vitamin C in a rat model of aging: implications for antioxidative defense. Biochem Biophys Res Commun. 2003;303(2):483-487.
36. Thum T, Tsikas D, Frolich JC, Borlak J. Growth hormone induces eNOS expression and nitric oxide release in a cultured human endothelial cell line. FEBS Lett. 2003;555(3):567-571.
37. Colao A, Di Somma C, Salerno M, Spinelli L, Orio F, Lombardi G The cardiovascular risk of GH-defcient adolescents. J Clin Endocrinol Metab. 2002;87(8):3650-3655.
38. Lanes R, Gunczler P, Lopez E, Esaa S, Villaroel O, Revel-Chion R. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-defcient adolescents. J Clin Endocrinol Metab. 2001;86(3):1061-1065.
39. Colao A, Di Somma C, Rota F, et al. Common carotid intima-media thickness in growth hormone (GH)-defcient adolescents: a prospective study after GH withdrawal and restarting GH replacement. J Clin Endocrinol Metab. 2005;90(5):2659-2665.
40. Clayton P, Gleeson H, Monson J, Popovic V, Shalet SM, Christiansen JS. Growth hormone replacement throughout life: insights into age-related responses to treatment. Growth Horm IGF Res. 2007;17(5):369-382.
41. Nilsson AG, Svensson J, Johannsson G. Management of growth hormone defciency in adults. Growth Horm IGF Res. 2007;17(6):441-462. (Pubitemid 350063727)
42. Ungvari Z, Bagi Z, Feher A, et al. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Physiol Heart Circ Physiol. 2010;299(1):H18-H24.
43. Lemieux ME, Yang X, Jardine K, et al. The Sirt1 deacetylase modulates the insulin-like growth factor signaling pathway in mammals. Mech Ageing Dev. 2005;126(10):1097-1105.
44. Vinciguerra M, Santini MP, Claycomb WC, Ladurner AG, Rosenthal N. Local IGF1 isoform protects cardiomyocytes from hypertrophic and oxidative stresses via SirT1 activity. Aging. 2010; 2(1):43-62.
45. Ungvari Z, Labinskyy N, Mukhopadhyay P, et al. Resveratrol attenuates mitochondrial oxidative stress in coronary arterial endothelial cells. Am J Physiol Heart Circ Physiol. 2009;297(5):H1876-H1881.
46. Csiszar A, Labinskyy N, Pinto JT, et al. Resveratrol induces mitochondrial biogenesis in endothelial cells. Am J Physiol Heart Circ Physiol. 2009;297(1):H13-H20.
47. Sun LY, Al-Regaiey K, Masternak MM, Wang J, Bartke A. Local expression of GH and IGF-1 in the hippocampus of GH-defcient long-lived mice. Neurobiol Aging. 2005;26(6):929-937.
48. Conover CA, Bale LK. Loss of pregnancy-associated plasma protein A extends lifespan in mice. Aging Cell. 2007;6(5):727-729.
49. Masternak MM, Al-Regaiey KA, Del Rosario Lim MM, et al. Caloric restriction and growth hormone receptor knockout: effects on expression of genes involved in insulin action in the heart. Exp Gerontol. 2006;41(4):417-429.
50. Maghnie M, Strigazzi C, Tinelli C, et al. Growth hormone (GH) defciency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab. 1999;84(4):1324-1328.
51. Forman K, Vara E, Garcia C, Ariznavarreta C, Escames G, Tresguerres JA. Cardiological aging in SAM model: effect of chronic treatment with growth hormone. Biogerontology. 2009;11(3):275-286.